Time Course of Haemostatic Effects of Fibrinogen Concentrate Administration in Aortic Surgery

Overview

Journal Br J Anaesth

Publisher Elsevier

Specialty Anesthesiology

Date 2013 Feb 8

PMID 23388508

Citations 31

Authors

C Solomon

C Hagl

N Rahe-Meyer

Affiliations

Soon will be listed here.

Abstract

Background: There is currently a contrast between the demonstrated benefits of fibrinogen concentrate in correcting bleeding and reducing transfusion, and its perceived thrombogenic potential. This analysis evaluates the effects of fibrinogen concentrate on coagulation up to 12 days after administration during aortic surgery.

Methods: We performed a post hoc analysis of a prospective, randomized, double-blind, controlled trial of fibrinogen concentrate as first-line haemostatic therapy in aortic surgery. After cardiopulmonary bypass (CPB) and protamine administration, subjects with coagulopathic bleeding received fibrinogen concentrate or placebo. The placebo group received allogeneic blood products, including fresh-frozen plasma (FFP; n=32); the fibrinogen concentrate group received fibrinogen concentrate alone (FC; n=14), or fibrinogen concentrate followed by allogeneic blood products (FC+FFP; n=15). Plasma fibrinogen, fibrin-based clotting (ROTEM(®)-based FIBTEM assay), and peri- and postoperative haematological and coagulation parameters were compared.

Results: Plasma fibrinogen and FIBTEM maximum clot firmness (MCF) decreased ∼50% during CPB but were corrected by FC or FC+FFP. At last suture, the highest values for plasma fibrinogen (360 mg dl(-1)) and FIBTEM MCF (22 mm) were within normal ranges--below the acute phase increases observed after surgery. In patients receiving only FFP as a source of fibrinogen, these parameters recovered marginally by last suture (P<0.001 vs FC and FC+FFP). All groups displayed comparable haemostasis at 24 h post-surgery. Fibrinogen concentrate did not cause alterations of other haemostasis parameters.

Conclusions: Fibrinogen concentrate provided specific, significant, short-lived increases in plasma fibrinogen and fibrin-based clot firmness after aortic surgery.

Citing Articles

Effect of cardiopulmonary bypass on coagulation factors II, VII and X in a primate model: an exploratory pilot study.

Shimoda T, Liu C, Mathis B, Goto Y, Ageyama N, Kato H Interdiscip Cardiovasc Thorac Surg. 2023; 37(6).

PMID: 38015856 PMC: 10701202. DOI: 10.1093/icvts/ivad194.

Weight-adjusted dosing of fibrinogen concentrate and cryoprecipitate in the treatment of hypofibrinogenaemic bleeding adult cardiac surgical patients: a analysis of the Fibrinogen Replenishment in cardiac surgery randomised controlled trial.

Devine C, Bartoszko J, Callum J, Karkouti K BJA Open. 2023; 2:100016.

PMID: 37588266 PMC: 10430806. DOI: 10.1016/j.bjao.2022.100016.

Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta-analysis.

Beverly A, Ong G, Kimber C, Sandercock J, Doree C, Welton N Cochrane Database Syst Rev. 2023; 2:CD013649.

PMID: 36800489 PMC: 9936832. DOI: 10.1002/14651858.CD013649.pub2.

Fibrinogen and albumin synthesis rates in major upper abdominal surgery.

Dumitrescu G, Januszkiewicz A, Agren A, Magnusson M, Sparrelid E, Rooyackers O PLoS One. 2022; 17(10):e0276775.

PMID: 36301906 PMC: 9612515. DOI: 10.1371/journal.pone.0276775.

Hypothermic circulatory arrest does not induce coagulopathy in vitro.

Ise H, Oyama K, Kunioka S, Shirasaka T, Kanda H, Akhyari P J Artif Organs. 2022; 25(4):314-322.

PMID: 35303203 PMC: 9643254. DOI: 10.1007/s10047-022-01324-5.

References

Weiner A, Reid D, ROBY C, DIAMOND L . Coagulation defects with intrauterine death from Rh isosensitization. Am J Obstet Gynecol. 1950; 60(5):1015-22. DOI: 10.1016/0002-9378(50)90507-2. View

Karlsson M, Ternstrom L, Hyllner M, Baghaei F, Flinck A, Skrtic S . Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost. 2009; 102(1):137-44. DOI: 10.1160/TH08-09-0587. View

Velik-Salchner C, Haas T, Innerhofer P, Streif W, Nussbaumer W, Klingler A . The effect of fibrinogen concentrate on thrombocytopenia. J Thromb Haemost. 2007; 5(5):1019-25. DOI: 10.1111/j.1538-7836.2007.02481.x. View

Solomon C, Rahe-Meyer N, Sorensen B . Fibrin formation is more impaired than thrombin generation and platelets immediately following cardiac surgery. Thromb Res. 2011; 128(3):277-82. DOI: 10.1016/j.thromres.2011.02.022. View

Ozier Y, Hunt B . Against: Fibrinogen concentrate for management of bleeding: against indiscriminate use. J Thromb Haemost. 2011; 9(1):6-8. DOI: 10.1111/j.1538-7836.2010.04083.x. View

STONE M, Thorp J . Plasma fibrinogen--a major coronary risk factor. J R Coll Gen Pract. 1985; 35(281):565-9. PMC: 1961456. View

Moerloose P, Neerman-Arbez M . Treatment of congenital fibrinogen disorders. Expert Opin Biol Ther. 2008; 8(7):979-92. DOI: 10.1517/14712598.8.7.979. View

Blome M, Isgro F, Kiessling A, Skuras J, Haubelt H, Hellstern P . Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost. 2005; 93(6):1101-7. DOI: 10.1160/TH04-12-0799. View

Solomon C, Traintinger S, Ziegler B, Hanke A, Rahe-Meyer N, Voelckel W . Platelet function following trauma. A multiple electrode aggregometry study. Thromb Haemost. 2011; 106(2):322-30. DOI: 10.1160/TH11-03-0175. View

10.

Kozek-Langenecker S, Sorensen B, Hess J, Spahn D . Emotional or evidence-based medicine--is there a moral tragedy in haemostatic therapy?. Crit Care. 2012; 15(6):462. PMC: 3388669. DOI: 10.1186/cc10583. View

11.

Volzke H, Robinson D, Kleine V, Hertwig S, Schwahn C, Grimm R . Preoperative plasma fibrinogen levels predict mortality after coronary artery bypass grafting. Thromb Haemost. 2003; 89(5):885-91. View

12.

Reinhart W . Fibrinogen--marker or mediator of vascular disease?. Vasc Med. 2004; 8(3):211-6. DOI: 10.1191/1358863x03vm494ra. View

13.

Lang T, Johanning K, Metzler H, Piepenbrock S, Solomon C, Rahe-Meyer N . The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg. 2009; 108(3):751-8. DOI: 10.1213/ane.0b013e3181966675. View

14.

Kozek-Langenecker S, Sorensen B, Hess J, Spahn D . Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care. 2011; 15(5):R239. PMC: 3334790. DOI: 10.1186/cc10488. View

15.

Raymond P, Ray M, Callen S, Marsh N . Heparin monitoring during cardiac surgery. Part 1: Validation of whole-blood heparin concentration and activated clotting time. Perfusion. 2003; 18(5):269-76. DOI: 10.1191/0267659103pf672oa. View

16.

Martini W . Fibrinogen availability and coagulation function after hemorrhage and resuscitation in pigs. Mol Med. 2011; 17(7-8):757-61. PMC: 3146596. DOI: 10.2119/molmed.2010.00093. View

17.

Birch H, Schreiber G . Transcriptional regulation of plasma protein synthesis during inflammation. J Biol Chem. 1986; 261(18):8077-80. View

18.

Theusinger O, Baulig W, Seifert B, Emmert M, Spahn D, Asmis L . Relative concentrations of haemostatic factors and cytokines in solvent/detergent-treated and fresh-frozen plasma. Br J Anaesth. 2011; 106(4):505-11. DOI: 10.1093/bja/aer003. View

19.

Solomon C, Pichlmaier U, Schoechl H, Hagl C, Raymondos K, Scheinichen D . Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth. 2010; 104(5):555-62. PMC: 2855672. DOI: 10.1093/bja/aeq058. View

20.

Otto J, Grenett H, Fuller G . The coordinated regulation of fibrinogen gene transcription by hepatocyte-stimulating factor and dexamethasone. J Cell Biol. 1987; 105(3):1067-72. PMC: 2114802. DOI: 10.1083/jcb.105.3.1067. View